Literature DB >> 8978777

Regional mapping of the human platelet-activating factor receptor gene (PTAFR) to 1p35-->p34.3 by fluorescence in situ hybridization.

P B Chase1, J M Yang, F H Thompson, M Halonen, J W Regan.   

Abstract

The human platelet-activating factor cell-surface receptor (PTAFR) is a G protein-coupled receptor thought to contribute to many atopic and inflammatory diseases and, perhaps, to the growth of some neoplasms. Exploring the possibility that the PTAFR might be involved in the genetic predisposition to any disease requires knowledge of its chromosomal localization. In this paper we have used a 20-kb human genomic fragment containing the coding sequence of the cloned PTAFR to determine the regional chromosomal localization of the gene. Using fluorescence in situ hybridization, the localization of the human PTAFR gene was mapped to 1p35-->p34.3.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8978777     DOI: 10.1159/000134190

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  4 in total

1.  Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.

Authors:  Cong Zhang; Qian Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

2.  Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.

Authors:  S Q Rice; C Southan; H F Boyd; J A Terrett; C H MacPhee; K Moores; I S Gloger; D G Tew
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

3.  Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival.

Authors:  G Ragnarsson; G Eiriksdottir; J T Johannsdottir; J G Jonasson; V Egilsson; S Ingvarsson
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

4.  Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor.

Authors:  Li Liu; Zhe Song; Xu-Dong Gao; Xian Chen; Xiao-Bin Wu; Mi Wang; Yu-De Hong
Journal:  BMC Cancer       Date:  2021-03-25       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.